Skip to main content
. 2018 Sep;16(5):428–435. doi: 10.1370/afm.2289

Table 1.

Baseline Characteristics of Patients in the Development and Validation Cohorts

Characteristic Development Cohort (n = 203) Validation Cohort (n = 415)
Unfavorable dizziness course,a No. (%) 150 (73.9) 181 (43.6)
Female, No. (%) 127 (62.6) 305 (73.5)
Age, mean (SD), y 77.5 (7.0) 78.5 (7.1)
Number of chronic diseases, mean (SD) 1.8 (1.4) 2.1 (1.4)
Number of drugs used, mean (SD) 5.5 (3.6) 4.4 (3.0)
Dizziness characteristics
DHI score,b mean (SD) [range] 46.2 (13.4) [30–88] 36.1 (19.9) [0–88]
Time since onset of dizziness, No. (%)
 0–4 weeks 3 (1.5) 29 (7.0)
 1–6 months 34 (16.7) 98 (23.6)
 6–48 months 49 (24.1) 109 (26.3)
 2–10 years 74 (36.5) 120 (28.9)
 >10 years 42 (21.2) 59 (14.2)
Description of dizziness, No. (%)c
 Instability or unsteadiness 162 (79.8) 280 (67.5)
 Loss of balance 165 (81.3) 287 (69.2)
 Lightheadedness 145 (71.4) 247 (59.5)
 Rotational sensation 137 (67.5) 228 (54.9)
 Tendency to fall 135 (66.5) 225 (54.2)
 Giddy 115 (56.7) 176 (42.2)
 Environment spinning 84 (41.4) 137 (33.0)
 Becoming unwell 60 (29.6) 114 (27.5)
 Near faint 59 (29.1) 96 (23.1)
 Everything turning black 39 (19.2) 68 (16.4)

DHI = Dizziness Handicap Inventory.

a

At 6 months of follow-up.

b

Score ranges from 0 to 100, with higher scores indicating more severe dizziness-related impairment.

c

Adds up to more than 100% because more than 1 answer was allowed.